Position in MGX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$354,283
-$74,030 QoQ
Shares Held
264,391
0.0% QoQ
Ownership
0.702%
of shares outstanding
% of Portfolio
2.44%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PURA VIDA INVESTMENTS, LLC holds $1,962,410 across 2 Biotechnology names. MGX ranks #2 (18.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAI |
Caris Life Sciences, Inc.
|
89,940 | $1,608,127 | |
| 2 | MGX |
Metagenomi Therapeutics, Inc.
This page
|
264,391 | $354,283 |
All Filings in MGX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $354,283 | 264,391 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $428,313 | 264,391 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $626,606 | 264,391 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,409,158 | 952,134 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $359,571 | 264,391 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $954,451 | 264,391 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $587,241 | 270,618 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,104,121 | 270,618 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,866,535 | 461,283 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||